Plastic Production and Human Health: From Factory to Body

Plastic is both miracle and curse. Its lightness, durability, and formability have enabled medical advances, food safety improvements, and engineering achievements that have saved lives. Its persistence in the environment, its chemical leaching into the food chain, and the toxic chemistry of its production and disposal have created a contamination problem of planetary scale that the 20th century never anticipated and the 21st is only beginning to grapple with.

The paradox of plastic is that many of its most celebrated properties — inertness, durability, resistance to degradation — are precisely the properties that make it an environmental and health problem once the product reaches the end of its useful life. A material designed to last forever, produced in quantities that exceed 400 million tonnes per year, with recycling rates below 10%, accumulates in the environment at rates that now mean plastic is detectable everywhere from the deepest ocean trenches to Arctic sea ice.

The health story of plastic operates at two levels: the chemistry of production (vinyl chloride, styrene, benzene — industrial carcinogens) and the chemistry of use and disposal (plasticiser migration, microplastic ingestion, chemical leaching from packaging). Both matter, and they affect different populations.

The chemical additives that give plastic its desired properties — flexibility, flame resistance, UV stability, colour, antimicrobial properties — are not chemically bonded to the polymer matrix. They can and do migrate from the plastic into whatever it contacts: food, beverages, body fluids in medical devices, and indoor air.

DEHP and phthalate migration DEHP (di-2-ethylhexyl phthalate) has been the primary plasticiser in flexible PVC for decades — used in medical tubing, IV bags, blood bags, food wrap, flooring, and wire insulation. It migrates continuously from the plastic into contact media, particularly at elevated temperatures and with fatty foods and lipid-containing fluids.

The medical device context is particularly concerning: patients receiving intensive care — with multiple IV lines, nasogastric tubes, and blood products in DEHP-plasticised containers — can receive DEHP doses far above general population exposure. Studies have found elevated DEHP metabolites in ICU patients. Neonatal ICUs have documented high DEHP exposure in premature infants through tube feeding — a particular concern given the developmental toxicity of phthalates.

Bisphenol A and epoxy lining migration As described in the BPA history article: BPA from can lining epoxy resins migrates into food, particularly when the can contains acidic or fatty content and when the food is heated. Canned tomatoes, canned fish, and canned soups are consistently among the highest BPA contributors in US dietary studies.

Microplastics — particles smaller than 5 millimetres — have been detected in every environmental compartment that has been systematically sampled: ocean water at all depths, Arctic and Antarctic ice, rain, human blood, human placenta, human lung tissue, and human breast milk.

The health implications of microplastic ingestion and inhalation are not yet fully characterised — this is an active research frontier — but several concerning findings have emerged.

Sources of human microplastic exposure: • Food and water: microplastics have been found in tap water, bottled water, sea salt, honey, and virtually all seafood categories tested. The median daily microplastic ingestion from food and water is estimated at several hundred to several thousand particles • Air inhalation: indoor air contains microplastic fibres from synthetic textiles, carpets, and plastic surface degradation. Studies have found elevated microplastic deposition in indoor environments compared to outdoor • Sea salt: derived from evaporated seawater, sea salt contains microplastics at measurable concentrations

The toxicological concern Microplastic particles themselves may have physical effects — inflammation from particle-cell interactions — but the chemical concern is what they carry: adsorbed persistent organic pollutants, heavy metals, and plastic additive chemicals that are concentrated on microplastic surfaces and potentially released when particles reach biological tissue.

A 2024 study found that patients with microplastics detected in their carotid artery plaques had higher rates of cardiovascular events than those without — the first prospective human evidence directly linking microplastic body burden to clinical outcomes.

A global plastics treaty — currently under negotiation at the UN — represents the most significant potential policy shift in plastic production and waste since the introduction of plastics themselves.

The current state of negotiations The UN Environment Assembly agreed in March 2022 to negotiate a legally binding global plastics treaty, with the goal of completing negotiations by the end of 2024. The treaty's scope is the central contested question: should it cover the full plastic lifecycle (production, design, use, and waste) or only waste management?

What a full-lifecycle treaty could achieve: • Production limits or phase-outs for specific high-risk plastic chemicals (DEHP, other endocrine-disrupting plasticisers) • Extended producer responsibility requirements that make plastic manufacturers financially responsible for end-of-life management • Design standards requiring recyclability and reducing or eliminating toxic additives • Restrictions on single-use plastics in categories with available alternatives

Consumer-level actions while policy develops:

Reducing microplastic release from textiles Synthetic textiles shed microfibers during washing — the primary source of microplastic in wastewater treatment plant effluent and receiving water bodies. A microfiber-catching washing bag (Guppyfriend) or washing machine filter (Filtrol) can reduce microfiber release by 80–90%.

Reducing plastic food contact The evidence for chemical migration from plastic food packaging is sufficient to support the shift to glass and stainless food storage described throughout this series. This reduces both phthalate and BPA exposure from food and reduces the demand signal for plastic packaging.